House Energy & Commerce Democratic leadership on Wednesday split over legislation to codify permission for state Medicaid programs to use value-based purchasing arrangements with drug makers for high-costs cell and gene therapies, as health subcommittee ranking Democrat Anna Eshoo (CA) backed the bill while full committee ranking Democrat Frank Pallone (NJ) said the bill is unnecessary and could have unintended consequences. The bill, which passed the committee 31-19, contains a provision that would codify a Trump-era regulation and change the...